Aktis Oncology, Inc. (AKTS)
18.14
+0.40
(+2.23%)
USD |
NASDAQ |
Oct 09, 16:00
18.14
0.00 (0.00%)
After-Hours: 16:58
Aktis Oncology Market Cap : 1.003B for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 981.36M |
| October 07, 2026 | 995.74M |
| October 06, 2026 | 988.00M |
| October 05, 2026 | 1.025B |
| October 02, 2026 | 1.025B |
| October 01, 2026 | 1.025B |
| September 30, 2026 | 1.077B |
| September 29, 2026 | 1.089B |
| September 28, 2026 | 1.070B |
| September 25, 2026 | 1.075B |
| September 24, 2026 | 1.086B |
| September 23, 2026 | 1.091B |
| September 22, 2026 | 1.223B |
| September 21, 2026 | 1.185B |
| September 18, 2026 | 1.210B |
| September 17, 2026 | 1.265B |
| September 16, 2026 | 1.256B |
| September 15, 2026 | 1.240B |
| September 14, 2026 | 1.282B |
| September 11, 2026 | 1.289B |
| September 10, 2026 | 1.324B |
| September 09, 2026 | 1.331B |
| September 08, 2026 | 1.384B |
| September 04, 2026 | 1.496B |
| September 03, 2026 | 1.474B |
| Date | Value |
|---|---|
| September 02, 2026 | 1.489B |
| September 01, 2026 | 1.438B |
| August 31, 2026 | 1.433B |
| August 28, 2026 | 1.426B |
| August 27, 2026 | 1.448B |
| August 26, 2026 | 1.467B |
| August 25, 2026 | 1.476B |
| August 24, 2026 | 1.437B |
| August 21, 2026 | 1.332B |
| August 20, 2026 | 1.328B |
| August 19, 2026 | 1.384B |
| August 18, 2026 | 1.383B |
| August 17, 2026 | 1.367B |
| August 14, 2026 | 1.379B |
| August 13, 2026 | 1.316B |
| August 12, 2026 | 1.328B |
| August 11, 2026 | 1.370B |
| August 10, 2026 | 1.332B |
| August 07, 2026 | 1.334B |
| August 06, 2026 | 1.296B |
| August 05, 2026 | 1.252B |
| August 04, 2026 | 1.263B |
| August 03, 2026 | 1.229B |
| July 31, 2026 | 1.220B |
| July 30, 2026 | 1.271B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.10B |
| Savara, Inc. | 1.012B |
| Vericel Corp. | 2.051B |
| Biogen, Inc. | 33.35B |
Market Cap Related Metrics
| PS Ratio | 98.62 |
| PEG Ratio | -0.0774 |
| Price to Book Value | 2.069 |
| Price | 18.14 |
| Earnings Yield | -7.60% |
| PEGY Ratio | -0.0774 |